CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Repetitive TMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03628703
NCT03628703N/ACompleted
CompareCT.gov

Using Repetitive Transcranial Magnetic Stimulation to Modulate Response Inhibition in Tourette Syndrome

Children's Hospital Medical Center, Cincinnati·interventional·Posted Aug 14, 2018·Updated Apr 18, 2024

In Brief

A clinical study evaluating Repetitive TMS for Tourette Syndrome. Completed, enrolled 10 participants across 1 site.

Detailed Summary

Tics are the hallmark symptoms in Tourette Syndrome. Patients with Tourette Syndrome have difficulties controlling unwanted movements. The ability to control the motor system involves the pre-supplementary motor area (pre-SMA) in the brain. In this study, we will use Transcranial Magnetic Stimulation to modulate the pre-SMA and determine effect on the ability to stop an unwanted action in a behavior task (stop signal task).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTourette Syndrome
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 14, 2018
Enrollment StartApr 22, 2019
Primary CompletionJun 30, 2023
Study CompletionMar 15, 2024
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 7.9 years ago

Interventions

Repetitive TMSdevice

Repetitive Intermittent Theta-Burst Transcranial Magnetic Stimulation over the right Pre-supplementary Motor Area